Results From the DoPING-HFpEF Trial: A Double Blind, Placebo-Controlled Randomized Cross-Over Trial Investigating Trimetazidine in Heart Failure With Preserved Ejection Fraction

被引：0
|
作者：
de Bovenkamp, Arno A. Van
Bakermans, Adrianus J. J.
Geurkink, Kiki J.
Oosterveer, Frank T.
De Man, Frances S.
Kok, Wouter E.
Nederveen, Aart J.
van Rossum, Albert C.
Handoko, M. Louis L.
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12368
引用
收藏
页数：3
相关论文
共 50 条
  • [31] A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine
    Bayer, Otmar
    Bremova, Tatiana
    Strupp, Michael
    Huefner, Katharina
    JOURNAL OF NEUROLOGY, 2018, 265 (02) : 291 - 298
  • [32] Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial
    Maxwell J. Roeske
    Maureen McHugo
    Baxter Rogers
    Kristan Armstrong
    Suzanne Avery
    Manus Donahue
    Stephan Heckers
    Neuropsychopharmacology, 2024, 49 : 681 - 689
  • [33] A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease
    Jose Luis López-Sendón Moreno
    Juan García Caldentey
    Patricia Trigo Cubillo
    Carolina Ruiz Romero
    Guillermo García Ribas
    M. A. Alonso Alonso Arias
    María Jesús García de Yébenes
    Rosa María Tolón
    Ismael Galve-Roperh
    Onintza Sagredo
    Sara Valdeolivas
    Eva Resel
    Silvia Ortega-Gutierrez
    María Laura García-Bermejo
    Javier Fernández Ruiz
    Manuel Guzmán
    Justo García de Yébenes Prous
    Journal of Neurology, 2016, 263 : 1390 - 1400
  • [34] Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial
    Roeske, Maxwell J.
    Mchugo, Maureen
    Rogers, Baxter
    Armstrong, Kristan
    Avery, Suzanne
    Donahue, Manus
    Heckers, Stephan
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 (04) : 681 - 689
  • [35] Modulation of Hippocampal Hyperactivity in Schizophrenia With Levetiracetam: a Randomized, Double-Blind, Cross-Over, Placebo-Controlled Trial
    Roeske, Maxwell
    McHugo, Maureen
    Rogers, Baxter
    Avery, Suzanne
    Armstrong, Kristan
    Heckers, Stephan
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 350 - 351
  • [36] Evaluation of Urolithin A Efficacy in Heart Failure Patients with Reduced Ejection Fraction: A Randomized, Double-blind, Crossover, Placebo-controlled Clinical Trial
    Jamialahmadi, Tannaz
    Hasanpour, Maede
    Vakilian, Farveh
    Penson, Peter E.
    Iranshahy, Milad
    Sahebkar, Amirhossein
    REVIEWS ON RECENT CLINICAL TRIALS, 2024, 19 (03) : 221 - 228
  • [37] Effects of melatonin on left ventricular ejection fraction and functional class of patients with heart failure: A randomized, double-blind, placebo-controlled trial
    Garakyaraghi, Mohammad
    Siavash, Mansour
    Alizadeh, Mohammad Kazem
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 : S13 - S16
  • [38] ENOXIMONE IN CHRONIC STABLE ANGINA - A DOUBLE-BLIND PLACEBO-CONTROLLED CROSS-OVER TRIAL
    DUBREY, SW
    GNANASAKTHY, A
    STEIN, WK
    SONG, JG
    HARDMAN, T
    HYND, J
    NOBLE, MIM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (04) : 532 - 538
  • [39] A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndrome
    Campbell, Kathleen
    Neul, Jeffrey L.
    Lieberman, David N.
    Berry-Kravis, Elizabeth
    Benke, Tim A.
    Fu, Cary
    Percy, Alan
    Suter, Bernhard
    Morris, David
    Carpenter, Randall L.
    Marsh, Eric D.
    von Hehn, Jana
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2025, 17 (01)
  • [40] Escitalopram in painful polyneuropathy: A randomized, placebo-controlled, cross-over trial
    Otto, Marit
    Bach, Flemming W.
    Jensen, Troels S.
    Brosen, Kim
    Sindrup, Soren H.
    PAIN, 2008, 139 (02) : 275 - 283
12345